DCTD Programs
Last Updated: 10/18/2019
DCTD’s Translational Research Program Announces Fiscal Year 2019 SPORE Grantees
The Translational Research Program (TRP) announced its successfully competed FY2019 Specialized Programs of Research Excellence (SPORE) grantees. The SPORE program uses the P50 and U54 grant funding mechanisms to promote collaborative, interdisciplinary, translational cancer multi-project research. SPOREs are primarily focused on organ site disease, but also on themes that cut across organ sites. Including the 2019 grantees, there are now 54 SPOREs located at academic centers in 20 states.
FY 2019 SPORE Grantees
| Principal Investigator | Institution | Cancer Type |
|---|---|---|
| *Tracy T. Batchelor | Brigham and Women’s Hospital | Brain |
| *Eric P. Winer | Dana-Farber Cancer Institute | Breast |
| *Adam Joel Bass and Nabeel El-Bardeesy | Dana-Farber Cancer Institute | Gastrointestinal |
| *Kenneth Anderson and Nikhil C. Munshi | Dana-Farber Cancer Institute | Myeloma |
| *John H. Sampson and Francis Ali-Osman | Duke University | Brain |
| Suresh S. Ramalingam and Haian Fu | Emory University | Lung |
| McGarry A. Houghton | Fred Hutchinson Cancer Research Center | Lung |
| *Tzyy-Choou Wu | Johns Hopkins University | Cervical |
| Iman Osman and Jeffrey S. Weber | New York University | Skin |
| *Robert E. Reiter | University of California, Los Angeles | Prostate |
| *Arul M. Chinnaiyan, Elisabeth Iljas Heath, and Ganesh S. Palapattu | University of Michigan, Ann Arbor | Prostate |
| *Frederick F. Lang and Juan Fueyo | University of Texas MD Anderson | Brain |
| Scott Kopetz and Anirban Maitra | University of Texas MD Anderson | Gastrointestinal |
| Laura Beretta and Ahmed Kaseb | University of Texas MD Anderson | Liver |
| Patrick Hwu | University of Texas MD Anderson | Skin |
| *Jennifer A. Pietenpol and Ingrid A. Mayer | Vanderbilt University Medical Center | Breast |
| Robert J. Coffey | Vanderbilt University Medical Center | Gastrointestinal |
*Grant Renewal
The goals of the SPORE program include:
- Translating novel scientific discoveries from the laboratory and/or population studies to the clinic for testing in humans with cancer or at risk for cancer
- Determining the biological basis for clinical observations
- Using specimens from clinical studies to determine correlations between biomarkers and outcomes in patients
- Promoting collaborations between SPOREs, Cancer Centers, other NCI/NIH funded mechanisms and programs, and outside organizations
- Promoting pilot projects and career enhancement of researchers new to translational research
- Supporting research in high incidence and rare cancers
- Encouraging communication with advocates and advocate organizations to obtain advice from the patient perspective
Contact TRP staff for more information on the SPORE program.